A funnel-shaped internal ion channel is surrounded by the five subunits. Muscarinic receptors, classified as G protein coupled receptors GPCR , are located at parasympathetic autonomically innervated visceral organs, on the sweat glands and piloerector muscles and both post-synaptically and pre-synaptically in the CNS see Table I. The muscarinic receptor is composed of a single polypeptide. Because each of these regions of the protein is markedly hydrophobic, they span the cell membrane seven times as depicted in Figure The fifth internal loop and the carboxyl-terminal tail of the polypeptide receptor are believed to be the site of the interaction of the muscarinic receptor with G proteins see right.
The site of agonist binding is a circular pocket formed by the upper portions of the seven membrane-spanning regions. ACh has excitatory actions at the neuromuscular junction, at autonomic ganglion, at certain glandular tissues and in the CNS. It has inhibitory actions at certain smooth muscles and at cardiac muscle. The biochemical responses to stimulation of muscarinic receptor involve the receptor occupancy causing an altered conformation of an associated GTP-binding protein G protein. In response to the altered conformation of the muscarinic receptor, the a subunit of the G protein releases bound guanosine diphosphate GDP and simultaneously binds guanosine triphosphate GTP.
This hydrolysis terminates the action of the G protein. The rate of hydrolysis of the GTP thus dictates the length of time the G protein remains activated. Inhibition of Adenylate Cyclase: The muscarinic receptor, through interaction with an inhibitory GTP-binding protein, acts to inhibit adenylyl cyclase. Reduced cAMP production leads to reduced activation of cAMP-dependent protein kinase , reduced heart rate, and contraction strength.
As shown in Figure The DAG activates protein kinase C not shown. Cellular responses are influenced by PKC's phosphorylation of target proteins. This conductance increase increases the resting membrane potential in myocardial and other cell membranes leading to inhibition. ACh binds only briefly to the pre- or postsynaptic receptors. Following dissociation from the receptor, the ACh is rapidly hydrolyzed by the enzyme acetylcholinesterase AChE as shown in Figure This enzyme has a very high catalysis rate, one of the highest known in biology.
AChE is synthesized in the neuronal cell body and distributed throughout the neuron by axoplasmic transport. AChE exists as alternatively spliced isoforms that vary in their subunit composition. The variation at the NMJ is a heteromeric protein composed of four subunits coupled to a collagen tail that anchors the multi-subunit enzyme to the cell membrane of the postsynaptic cell Figure This four-subunit form is held together by sulfhydryl bonds and the tail anchors the enzyme in the extracellular matrix at the NMJ.
Other isoforms are homomeric and freely soluble in the cytoplasm of the presynaptic cell. In addition, other cholinesterases exist throughout the body, which are also able to metabolize acetylcholine. These are termed pseudocholinesterases. Yet, fundamental issues concerning the precise distribution and location of the enzyme in the cleft remained open: whether and to what extent synaptic AChE is associated with pre- or postsynaptic membranes, or with synaptic basal lamina BL , and whether it occurs only in the primary cleft PC or also in postjunctional folds PJFs.
Nanogold-conjugates of fasciculin, an anticholinesterase polypeptide toxin, were prepared and used to label AChE at NMJs of mouse and frog muscles.
Quantitative analysis demonstrated that AChE sites are almost exclusively located on the BL rather than on pre- or postsynaptic membranes and are distributed in the PC and down the PJFs, with a defined pattern. This localization pattern of AChE is suggested to ensure full hydrolysis of acetylcholine ACh bouncing off receptors, thus eliminating its unnecessary detrimental reattachment. Acetylcholinesterase AChE is concentrated at neuromuscular junctions NMJs and other cholinergic synapses in the central and peripheral nervous systems.
Its required functional role at a given type of synapse is determined by its concentration and distribution within the synaptic cleft. Subsequently, we developed an I-labeled probe that utilizes the potent anticholinesterase snake venom toxin, fasciculin Fas; Karlsson et al. Although EM-autoradiography is a powerful tool for measuring densities, it does not offer the resolution required for fine localization of AChE.
Thus, the precise distribution and location of the enzyme in the cleft could not be determined. Several basic questions remained to be resolved, such as whether and to what extent synaptic AChE is associated with pre- or postsynaptic surfaces within the cleft, or with the synaptic basal lamina BL. The differences in AChE origin and isoform composition could result in differential localization within the synaptic cleft.
Another issue that demands fine resolution of AChE distribution is whether synaptic AChE is found only in the primary cleft PC or also in postjunctional folds PJFs , and what is its precise distribution within the fold.
This information is crucial for understanding the role of AChE in terminating synaptic transmission. In the present study we developed new probes for high resolution EM-localization of AChE, based on conjugates of nanogold particles with the anticholinesterase polypeptide toxin, Fas.
These probes were then used to determine the precise localization and distribution of AChE within the synaptic cleft of the intact vertebrate NMJ.
AChE in the PC was found to be closer to the myofiber than to the nerve terminal, in keeping with its association with the BL. The localization that we have established for normal vertebrate NMJs provides a benchmark for comparison in studies of NMJs following changes in physiological and pathological conditions. Materials were purchased from Sigma-Aldrich Inc. Hazen Frog Co. The I-Fas preparation was tested for its capacity to inhibit AChE activity by the colorimetric assay of Ellman et al.
Silman Weizmann Institute, Israel; detailed in Anglister et al. The right sternomastoid muscle was exposed by an incision in the neck, and the skin was held back so as to create a well.
Frogs, anesthetized by immersion in water containing 0. Labeling of mouse sternomastoid muscles followed our earlier protocol Anglister et al. The experimental group included three mice. The muscles were then excised, and fixed for a further 1 h in the paraformaldehyde, followed by washing with 0.
The mice with muscles labeled by Fas-biotin were maintained under anesthesia, while the muscles were treated with 1. The mice were then sutured and allowed to wake, to permit further wash-out of the muscles see above. In all preparations, nanogold labeling was intensified with HQ-silver Molecular Probes; 4 min in the dark , and stabilized with gold-toning as specified in the Nanoprobes Instruction Manual.
The specimens were then post fixed in 0. Subsequently the muscles were treated with the labeled-Fas sequence, fixed and processed as the experimental specimen. In additional control, exposed muscles were directly treated with nanogold-streptavidin or just nanogold particles , omitting the Fas labeling altogether, and then continued as described above.
No detectable gold-particles were observed at the NMJs of either of the control muscles preparations. The presynaptic axonal membrane and the opposing postsynaptic muscle membrane, including the PJFs, were outlined. The shortest distances of each gold particle from the axonal and muscle membranes were measured. In the same way, the locations of the BL boundaries adjacent to each gold particle were measured, taking the location of the presynaptic membrane as zero in the PC. Those measured in the PJF were normalized by the width or length of the fold, as detailed in the specific experiments Figures 3 , 4.
Measurements from electron micrographs of examined synaptic sites were collected for each mouse. Figure 1. Distribution of Acetylcholinesterase AChE sites within the synaptic cleft. Mouse sternomastoid muscles were incubated with I-Fas 0.
They were then rinsed, fixed and processed for EM-autoradiography. Grains appeared almost exclusively at the NMJs. N, nerve; M, muscle. B Radioactivity is distributed over the full depth of the PJFs. The bottom of the PJFs is on the average 11 HD arrow , but with a large range; consequently, it is not as sharp a boundary as that provided by the axonal membrane. Figure 2. Distribution of nanogold-labeled AChE sites in the synaptic cleft of the mouse endplate. A,B Electron micrographs of cross sections through endplates of mouse sternomastoid muscles that had been incubated with Fas-biotin followed by 1.
Bars, 0. Figure 3. AChE distribution in the PC of a mouse sternomastoid endplate. Distances from the axonal pre-synaptic membrane 0. Most gold particles are found on the synaptic BL blue and green lines connect the BL border measurements on either side in the PC between the presynaptic axonal membrane 0. The histogram of the gold-particles orange, upper panel relative to the histograms of the BL boundaries green-blue, lower panel shows that the AChE sites are mainly spread over the BL in the PC.
It should be noted that the AChE sites are predominantly closer to the postsynaptic muscle membrane than to the presynaptic nerve membrane. Figure 4. A Distribution across the width of the PJF. Ferreira De Oliveira, G. Gajo, and D. Zanetti, J. Zanuncio, J. Santos, W. Da Silva, G. Ribeiro, and P. Rahimi, S. Nikfar, and M. Shadnia, E. Azizi, R. Hosseini et al.
Suarez-Lopez, D. Jacobs Jr. Himes, and B. Ye, J. Beach, J. Martin, and A. Ellman, K. Courtney, V. Andres Jr. Shevchenko, M. Wilm, O. Vorm, and M. Adalberto, C. Golfeto, A. Moreira et al. Ike, A. Moreira, F. Dereeper, V. Guignon, G. Blanc et al. W—W, Stecher, and K. Vanzolini, L. Vieira, A. Cardoso, and Q. Moreira, A.
Santos, R. Carneiro, O. Bueno, and D. Mohamed, E. Mahdy, A. Ghazy, N. Ibrahim, H. El-Mezayen, and M. Cass and N. Adalberto and D. Souza, Eds. View at: Google Scholar L. Xiao, W. Dou, Y. Li, and J. Cass, and C. Cui, W. Wu, M. Li, X. Song, Y. Lv, and T. Gabrovska, I. Marinov, T. Godjevargova et al. Fournier, G. Ketoh, I. Glitho, R. Nauen, and T. Moyo, A. Ndhlala, J.
Finnie, and J. Wang, F. Li, K. Xu et al. Ye, C. Li, J. Yang et al. It inserts into the active site pocket and temporarily blocks entry of acetylcholine. Other poisons, as shown next, take a more permanent approach. The nerve toxin sarin and insecticides such as malathion directly attack the active site machinery of acetylcholinesterase. The structure shown here, from PDB entry 1cfj , shows the active site triad of acetylcholinesterase after being poisoned by sarin. In the normal reaction, the serine amino acid forms a bond to the acetyl group of acetylcholine, breaking the molecule.
Then, in a matter of microseconds, a water molecule breaks the new bond, releasing acetic acid and restoring the serine to its original form. Sarin, however, transfers a nasty methylphosphonate group MeP in the picture to the serine.
The phosphonate is far more stable and will disable the enzyme for hours or days. This picture was created with RasMol. You can create similar pictures by clicking on the accession codes and picking one of the options for 3D viewing. References P. Taylor The Cholinesterases. Journal of Biological Chemistry , Taylor and Z. Radic The Cholinesterases: From genes to Proteins. Annual Review of Pharmacology and Toxicology 34, In Neuropsychopharmacology, K. Davis, D. Charney, J.
0コメント